![Erica Kratz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 707 204 $ al 31/07/2026
Erica Kratz is Chief Regulatory & Quality Officer at Aura Biosciences, Inc. since 2026.
Formerly, Dr. Kratz was Vice President-Regulatory at Denali Therapeutics, Inc. from 2022 to 2026.
Education includes undergraduate studies at the University of Arizona and a doctorate from the University of California.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
AURA BIOSCIENCES INC 0,1 % | 01/09/2026 | 100.885 ( 0,1 % ) | 707 204 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| AURA BIOSCIENCES, INC. | Consejero General | 11/08/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
| DENALI THERAPEUTICS INC. | Consejero General | 01/05/2026 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Aura Biosciences, Inc.
 Aura Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company leveraging novel targeted oncology platform to develop new standard of care across multiple cancer indications | Health Technology |
University of Arizona
 University of Arizona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California
 University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Denali Therapeutics, Inc.
 Denali Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for neurodegenerative diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
